Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 4076 - 4100 of 4207 in total
Experimental
Matched Name: … 4-{[5-(CYCLOHEXYLOXY)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE …
Matched Iupac: … 4-{[5-(cyclohexyloxy)-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl]amino}benzene-1-sulfonamide …
Experimental
Matched Name: … 2-(4-CHLOROBENZYLAMINO)-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE …
Matched Iupac: … 2-{[(4-chlorophenyl)methyl]amino}-4-(phenylamino)pyrazolo[1,5-a][1,3,5]triazine-8-carbonitrile …
Experimental
Matched Name: … 3-methyl-N-(pyridin-4-ylmethyl)imidazo[1,2-a]pyrazin-8-amine …
Matched Iupac: … 3-methyl-N-[(pyridin-4-yl)methyl]imidazo[1,2-a]pyrazin-8-amine …
Experimental
Matched Name: … 8-(6-BROMO-BENZO[1,3]DIOXOL-5-YLSULFANYL)-9-(3-ISOPROPYLAMINO-PROPYL)-ADENINE
An adrenergic agonist that acts predominantly at alpha adrenergic receptors and also stimulates the release of norepinephrine. It has been used primarily as a vasoconstrictor in the treatment of hypotension.
Approved
Investigational
Matched Synonyms: … L-Metaraminol …
Matched Description: … An adrenergic agonist that acts predominantly at alpha adrenergic receptors and also stimulates the release ... It has been used primarily as a vasoconstrictor in the treatment of hypotension. …
Matched Categories: … Adrenergic and Dopaminergic Agents …
Gout is a disease that occurs by the deposition of monosodium urate crystals (MSU) in body tissues, especially around joints . This disease has been well-documented in historical medical records and appears in the biographies of several prominent, historically recognized individuals . Allopurinol is a xanthine oxidase enzyme inhibitor that...
Approved
Matched Description: … This disease has been well-documented in historical medical records and appears in the biographies of ... drugs used to decrease urate levels and is frequently used in the treatment of chronic gout [A36705] ... It was initially approved by the FDA in 1966 [L5674] and is now formulated by several manufacturers [ …
Matched Categories: … Preparations Inhibiting Uric Acid Production ... Drugs that are Mainly Renally Excreted …
Matched Products: … CORIC 100 ... Ag-allopurinol ... Apo-allopurinol …
An anionic surface-active agent used for its wetting properties in industry and used in medicine as an irritant and sclerosing agent for hemorrhoids and varicose veins.
Approved
Investigational
Matched Synonyms: … Natrii tetradecylis sulfa
Matched Description: … An anionic surface-active agent used for its wetting properties in industry and used in medicine as an ... irritant and sclerosing agent for hemorrhoids and varicose veins. …
Matched Categories: … Sulfur Acids ... Compounds used in a research, industrial, or household setting ... Sulfur Compounds ... Acids ... Alkanesulfonic Acids
Experimental
Matched Synonyms: … (1R,2R,3S,4R,6S)-4,6-diamino-2-{[3-O-(2,6-diamino-2,6-dideoxy-β-L-idopyranosyl)-2-O-{2-[(piperidin-3- …
Matched Name: … (1R,2R,3S,4R,6S)-4,6-diamino-2-{[3-O-(2,6-diamino-2,6-dideoxy-beta-L-idopyranosyl)-2-O-{2-[(piperidin …
Alteplase is a recombinant tissue plasminogen activator (rt-PA) used as a thrombolytic agent. It cleaves plasminogen to form plasmin, an enzyme involved in the degradation of fibrin clots. In the absence of fibrin, the alteplase-mediated conversion of plasminogen is limited, thanks to the high affinity between alteplase and fibrin.[A252330,L43125] Alteplase...
Approved
Investigational
Matched Synonyms: … Plasminogen activator (human tissue-type protein moiety) …
Matched Description: … such as angioplasty and stenting. ... [A252330,L43125] Alteplase is a purified glycoprotein of 527 amino acids expressed in Chinese hamster ... [tenecteplase] and [reteplase], have also been developed. …
Matched Categories: … Amino Acids, Peptides, and Proteins ... Enzymes and Coenzymes ... Blood and Blood Forming Organs ... Proteins ... Blood Proteins
Investigational
Matched Synonyms: … G 1 (g protein-coupled estrogen receptor agonist) …
Matched Name: … LNS-8801 …
Experimental
Matched Name: … 2-Hydroxy-5-({1-[(4-Methylphenoxy)Methyl]-3-Oxoprop-1-Enyl}Amino)-L-Tyrosine …
Matched Iupac: … 2S)-2-amino-3-(2,4-dihydroxy-5-{[(2E)-1-(4-methylphenoxy)-4-oxobut-2-en-2-yl]amino}phenyl)propanoic acid
Experimental
Matched Name: … octyl 3-deoxy-2-O-(6-deoxy-alpha-L-galactopyranosyl)-beta-D-xylo-hexopyranoside …
Experimental
Matched Name: … (2R,3R)-7-(methylsulfonyl)-3-(2,4,5-trifluorophenyl)-1,2,3,4-tetrahydropyrido[1,2-a]benzimidazol-2-amine …
Experimental
Matched Name: … 3-bromo-5-phenyl-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine …
Matched Iupac: … 3-bromo-5-phenyl-N-[(pyridin-4-yl)methyl]pyrazolo[1,5-a]pyrimidin-7-amine …
Experimental
Matched Name: … 3-bromo-5-phenyl-N-(pyridin-3-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine …
Matched Iupac: … 3-bromo-5-phenyl-N-[(pyridin-3-yl)methyl]pyrazolo[1,5-a]pyrimidin-7-amine …
C1 Esterase Inhibitor (Human) is composed of purified endogenous complement component-1 esterase inhibitor (hC1INH) isolated from human plasma. The primary function of endogenous C1INH is to regulate the activation of the complement and contact system pathways.[L16586, L16606] This drug is indicated for prophylaxis and treatment of Hereditary Angioedema (HAE), a...
Approved
Matched Synonyms: … Plasma protease C1 inhibitor …
Matched Description: … The primary function of endogenous C1INH is to regulate the activation of the complement and contact ... [L16586, L16606] This drug is indicated for prophylaxis and treatment of Hereditary Angioedema (HAE ... The disease is characterized by acute attacks of painful, and in some cases, fatal swelling of several …
Matched Categories: … Amino Acids, Peptides, and Proteins ... Blood and Blood Forming Organs ... Proteins ... Blood Proteins ... Protease Inhibitors …
Solifenacin is a competitive muscarinic receptor antagonist indicated to treat an overactive bladder with urinary incontinence, urgency, and frequency. It has a long duration of action as it is usually taken once daily. Solifenacin was granted FDA approval on 19 November 2004.
Approved
Matched Description: … with urinary incontinence, urgency, and frequency. ... [L7511] It has a long duration of action as it is usually taken once daily. ... Solifenacin is a competitive muscarinic receptor antagonist indicated to treat an overactive bladder …
Matched Salts name: … Solifenacin hydrochloride
Matched Categories: … tamsulosin and solifenacin ... Genito Urinary System and Sex Hormones ... Drugs for Urinary Frequency and Incontinence …
Matched Products: … VESIcare LS ... SOLIFENACINA L M ... SOLIFENACIN MICRO LAB 5MG …
Investigational
Matched Synonyms: … -L-TALO-HEPTOFURANURONAMIDE, 5-O-(5-AMINO-5-DEOXY-.BETA. …
A flavonol glycoside found in many plants, including buckwheat; tobacco; forsythia; hydrangea; viola, etc. It has been used therapeutically to decrease capillary fragility.
Approved
Experimental
Investigational
Matched Synonyms: … 3-[[6-O-(6-Deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyl]oxy]-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy …
Matched Description: … A flavonol glycoside found in many plants, including buckwheat; tobacco; forsythia; hydrangea; viola, …
Matched Mixtures name: … KORDEL`S C TIME ACID FREE C 1000MG TABLET ... Nutriforte Non-Acidic Vitamin C 1000 mg with Bioflavonoids …
Investigational
Matched Synonyms: … Recombinant human porphobilinogen deaminase, erythropoietic form
Ebola virus vaccine is a vaccine used to prevent Ebola virus disease caused by Zaire ebolavirus in adults, prevent outbreaks, and reduce the extent of the virus spreading in case of outbreaks. Ebola virus disease, formerly known as Ebola hemorrhagic fever, is a rare but severe and often deadly disease....
Approved
Matched Synonyms: … Recombinant Vesicular Stomatitis Virus (rVSV) strain Indiana with a deletion of the VSV envelope glycoprotein …
Matched Description: … These may be accompanied by hypotension and respiratory, kidney and liver failure, as well as internal ... [L10854] Ebola virus disease, formerly known as Ebola hemorrhagic fever, is a rare but severe and often ... and external bleeding. …
Experimental
Matched Name: … 5-(2,3-dichlorophenyl)-N-(pyridin-4-ylmethyl)-3-thiocyanatopyrazolo[1,5-a]pyrimidin-7-amine …
Matched Iupac: … {[5-(2,3-dichlorophenyl)-7-{[(pyridin-4-yl)methyl]amino}pyrazolo[1,5-a]pyrimidin-3-yl]sulfanyl}formonitrile …
Experimental
Matched Name: … 7-carboxy-5-hydroxy-12,13-dihydro-6H-indolo[2,3-a]pyrrolo[3,4-c]carbazole …
Matched Iupac: … }.0^{4,9}.0^{11,15}.0^{17,22}]tricosa-1(16),2(10),4(9),5,7,11,14,17(22),18,20-decaene-12-carboxylic acid
Experimental
Matched Name: … 5-[(4-AMINOCYCLOHEXYL)AMINO]-7-(PROPAN-2-YLAMINO)PYRAZOLO[1,5-A]PYRIMIDINE-3-CARBONITRILE …
Matched Iupac: … 7-[(propan-2-yl)amino]-5-{[(1r,4r)-4-aminocyclohexyl]amino}pyrazolo[1,5-a]pyrimidine-3-carbonitrile …
Erlotinib is an inhibitor of the epidermal growth factor receptor (EGFR) tyrosine kinase that is used in the treatment of non-small cell lung cancer, pancreatic cancer and several other types of cancer. It is typically marketed under the trade name Tarceva. Erlotinib binds to the epidermal growth factor receptor (EGFR)...
Approved
Investigational
Matched Description: … at the adenosine triphosphate (ATP) binding site of the receptor. ... form of tyrosine kinase JAK2 found in most patients with polycythemia vera (PV) and a substantial proportion ... in the treatment of non-small cell lung cancer, pancreatic cancer and several other types of cancer. …
Matched Salts name: … Erlotinib hydrochloride
Matched Categories: … Antineoplastic and Immunomodulating Agents ... Protein Kinase Inhibitors ... P-glycoprotein substrates with a Narrow Therapeutic Index ... Cytochrome P-450 CYP1A2 Substrates with a Narrow Therapeutic Index ... Cytochrome P-450 CYP2C8 Substrates with a Narrow Therapeutic Index …
Matched Products: … Apo-erlotinib ... Erlotinib Hydrochloride
Displaying drugs 4076 - 4100 of 4207 in total